↓ Skip to main content

Atropine vs Patching for Treatment of Moderate Amblyopia: Follow-up at 15 Years of Age of a Randomized Clinical Trial

Overview of attention for article published in JAMA Ophthalmology, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
21 X users

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
149 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Atropine vs Patching for Treatment of Moderate Amblyopia: Follow-up at 15 Years of Age of a Randomized Clinical Trial
Published in
JAMA Ophthalmology, July 2014
DOI 10.1001/jamaophthalmol.2014.392
Pubmed ID
Authors

Michael X. Repka, Raymond T. Kraker, Jonathan M. Holmes, Allison I. Summers, Stephen R. Glaser, Carmen N. Barnhardt, David R. Tien

Abstract

Initial treatment for amblyopia of the fellow eye with patching and atropine sulfate eyedrops improves visual acuity. Long-term data on the durability of treatment benefit are needed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 21 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 <1%
Unknown 148 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 18 12%
Researcher 15 10%
Student > Master 13 9%
Student > Postgraduate 10 7%
Student > Doctoral Student 10 7%
Other 35 23%
Unknown 48 32%
Readers by discipline Count As %
Medicine and Dentistry 57 38%
Nursing and Health Professions 7 5%
Neuroscience 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Psychology 3 2%
Other 12 8%
Unknown 60 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2016.
All research outputs
#1,435,698
of 25,374,647 outputs
Outputs from JAMA Ophthalmology
#749
of 6,642 outputs
Outputs of similar age
#14,036
of 242,347 outputs
Outputs of similar age from JAMA Ophthalmology
#7
of 111 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,642 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.7. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,347 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.